반응식
Br[C:2]1[CH:19]=[CH:18][C:5]2[N:6]=[C:7]([N:9]3[CH2:14][CH2:13][N:12]([CH:15]4[CH2:17][CH2:16]4)[CH2:11][CH2:10]3)[S:8][C:4]=2[CH:3]=1.B(O)(O)[C:21]1[C:26]([Cl:27])=[CH:25][N:24]=[C:23]([O:28][CH3:29])[CH:22]=1.CC(O[K])=O>CN(C=O)C.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[Cl:27][C:26]1[C:21]([C:2]2[CH:19]=[CH:18][C:5]3[N:6]=[C:7]([N:9]4[CH2:14][CH2:13][N:12]([CH:15]5[CH2:17][CH2:16]5)[CH2:11][CH2:10]4)[S:8][C:4]=3[CH:3]=2)=[CH:22][C:23]([O:28][CH3:29])=[N:24][CH:25]=1참가 물질
6
반응물 3
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 80 °C
실험 절차
To a solution of 6-bromo-2-(4-cyclopropylpiperazin-1-yl)benzothiazole (500 mg, 1.48 mmol) and 5-chloro-2-methoxypyridin-4-yl-4-boronic acid (334 mg, 1.78 mmol) in DMF (20 mL) was added PdCl2(dppf) (108 mg, 0.148 mmol), followed by CH3COOK (581 mg, 5.92 mmol). The mixture was heated at 80° C. for 2 h, filtered and the volatiles evaporated. Water (5 mL) was added and the mixture was extracted with CH2Cl2 (3×5 mL). The combined organic extracts were dried (Na2SO4) and concentrated. The residue was purified by the preparative HPLC to give 35 mg (6%) of 6-(5-chloro-2-methoxypyridin-4-yl)-2-(4-cyclopropylpiperazin-1-yl)benzothiazole as a trifluoroacetate salt.
후처리
- filtrationfiltered
- customthe volatiles evaporated
- additionWater (5 mL) was added
- extractionthe mixture was extracted with CH2Cl2 (3×5 mL)
- dry with materialThe combined organic extracts were dried (Na2SO4)
- concentrationconcentrated
- customThe residue was purified by the preparative HPLC
출처 및 근거
- ORD 기록
- ord-f527a6e539aa43ec8b9cc303bf4025d2
- 출처 데이터셋
- uspto-grants-2013_03
- 특허 번호
- US08394842B2
연결된 노트
불러오는 중…